We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.06%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.89B
AUM Growth
+$8.03M
Cap. Flow
+$48.2M
Cap. Flow %
1.24%
Top 10 Hldgs %
14.93%
Holding
1,432
New
121
Increased
566
Reduced
530
Closed
107

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.2M
2
CSCO icon
Cisco
CSCO
+$6.27M
3
EMR icon
Emerson Electric
EMR
+$5.92M
4
HA
Hawaiian Holdings, Inc.
HA
+$5.41M
5
ACM icon
Aecom
ACM
+$5.1M

Sector Composition

Rank Sector Weight
1 Healthcare 13.29%
2 Financials 11.98%
3 Technology 11.97%
4 Industrials 9.85%
5 Consumer Discretionary 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
176
Colgate-Palmolive
CL
$73.1B
$4.95M 0.13%
69,005
-14,365
-17% -$1.03M
ROBO icon
177
ROBO Global Robotics & Automation Index ETF
ROBO
$1.96B
$4.92M 0.13%
117,623
+9,366
+9% +$406K
PLNT icon
178
Planet Fitness
PLNT
$4.42B
$4.91M 0.13%
130,000
COP icon
179
ConocoPhillips
COP
$147B
$4.88M 0.13%
82,258
+1,097
+1% +$62K
ABEV icon
180
Ambev
ABEV
$48.1B
$4.87M 0.13%
670,323
-4,260
-0.6% -$29.3K
PX
181
DELISTED
Praxair Inc
PX
$4.85M 0.12%
33,635
-1,562
-4% -$243K
VUG icon
182
Vanguard Morningstar Growth ETF
VUG
$220B
$4.84M 0.12%
204,636
+14,286
+8% +$348K
XBI icon
183
State Street SPDR S&P Biotech ETF
XBI
$9.95B
$4.73M 0.12%
53,915
+10,953
+25% +$1,000K
ELV icon
184
Elevance Health
ELV
$81.5B
$4.71M 0.12%
21,457
-2,270
-10% -$533K
LLL
185
DELISTED
L3 Technologies, Inc.
LLL
$4.71M 0.12%
22,653
-3,615
-14% -$749K
WP
186
DELISTED
Worldpay, Inc.
WP
$4.7M 0.12%
57,149
+396
+0.7% +$31.4K
CBRE icon
187
CBRE Group
CBRE
$42.5B
$4.65M 0.12%
98,478
+56,685
+136% +$2.58M
IBB icon
188
iShares Biotechnology ETF
IBB
$9.34B
$4.63M 0.12%
43,352
-2,347
-5% -$260K
PSX icon
189
Phillips 66
PSX
$84.9B
$4.61M 0.12%
48,070
+5,120
+12% +$498K
CIM
190
Chimera Investment
CIM
$1.04B
$4.61M 0.12%
88,239
+3
+0% +$157
J icon
191
Jacobs Solutions
J
$15.9B
$4.6M 0.12%
94,078
-3,748
-4% -$198K
GSK icon
192
GSK
GSK
$104B
$4.57M 0.12%
93,632
+33,790
+56% +$1.57M
CVS icon
193
CVS Health
CVS
$133B
$4.55M 0.12%
73,159
+7,388
+11% +$530K
LLY icon
194
Eli Lilly
LLY
$1.02T
$4.44M 0.11%
57,416
+3,215
+6% +$259K
FDX icon
195
FedEx
FDX
$72.7B
$4.42M 0.11%
18,426
+170
+0.9% +$43K
GLW icon
196
Corning
GLW
$119B
$4.42M 0.11%
158,322
-2,325
-1% -$71.7K
CY
197
DELISTED
Cypress Semiconductor
CY
$4.41M 0.11%
260,216
-3,082
-1% -$52.8K
CHKP icon
198
Check Point Software Technologies
CHKP
$13B
$4.41M 0.11%
44,355
-1,822
-4% -$188K
TJX icon
199
TJX Companies
TJX
$174B
$4.4M 0.11%
107,944
+560
+0.5% +$22.1K
ADP icon
200
Automatic Data Processing
ADP
$106B
$4.4M 0.11%
38,751
+84
+0.2% +$9.79K

Similar funds

Oppenheimer & Co's Q1 2018 Portfolio in Review

As of Q1 2018, Oppenheimer & Co held 1,432 positions worth $3.89B, up 0.21% from $3.88B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q1 2018 filing shows 121 new, 566 increased, 530 reduced and 107 closed positions. Its largest new stake was Pricesmart: 38,950 shares worth $3.25M. The largest sale was Meta Platforms (Facebook), an estimated $15.8M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q1 2018 buy was Pricesmart: 38,950 shares worth $3.25M.
  • Oppenheimer & Co added most to Microsoft in Q1 2018, an estimated $12.2M increase.
  • Oppenheimer & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $15.8M.
  • Oppenheimer & Co fully exited Polaris in Q1 2018, selling an estimated $4M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $3.89B portfolio in Q1 2018.
  • Oppenheimer & Co opened 121 new positions and closed 107 in Q1 2018.
  • Oppenheimer & Co's portfolio value rose 0.21% quarter-over-quarter to $3.89B.

Based on Oppenheimer & Co's 13F filing for Q1 2018, filed 1 May 2018.